Immunology

New serology assays

Vircell has added a number of new assays to its VirClia range, enhancing the extensive portfolio of chemiluminescent monotests for infectious disease serology.

Blood glucose and type 1 diabetes

A study shows that a gene therapy approach can lead to long-term survival for functional beta cells, as well as normal blood glucose levels for an extended period of time in mice with type 1 diabetes. 

Fighting breast cancer

A combination of oncolytic viruses and checkpoint inhibitors could be more successful than traditional treatments in fighting breast cancer, and possibly other cancers too.

Science news in numbers: February

A breakdown of science news this month.

Cholera vaccine: single dose more effective?

New research shows that giving a stronger single dose of a live oral cholera vaccine could be an effective tool in controlling outbreaks more quickly.

Science news in numbers: January 2018

A breakdown of science news this month.

"HIV vaccine design shows promise"

A novel protein-sugar vaccine candidate has stimulated an immune response against sugars that form a protective shield around HIV.

Four decades of tuberculosis

Professor Douglas Young discusses the last 40 years of tuberculosis research, as he hangs up his lab coat for the final time.

Chemo-boosting Drug

Drugs developed to treat heart and blood vessel problems could be used in combination with chemot

UK biomedical catalyst award

Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases and cancer, has been awarded up to £945,000 under Innovate UK’s Biomedical Catalyst programme.

Top